Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “SENTINEL ONCOLOGY LIMITED”

11 pharma patents match "SENTINEL ONCOLOGY LIMITED" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 11
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 11 pharmaceutical patents matching "SENTINEL ONCOLOGY LIMITED" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

11 results for “SENTINEL ONCOLOGY LIMITED” · 30,257 patents in full index Clear search

  1. US 11884656

    Pyrrole derivatives as PLK1 inhibitors

    SENTINEL ONCOLOGY LIMITED · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  2. US 11786524

    Pharmaceutical compounds

    SENTINEL ONCOLOGY LIMITED · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted
  3. US 11208405

    Pyrrole derivatives as PLK1 inhibitors

    SENTINEL ONCOLOGY LIMITED · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  4. US 10973817

    Pharmaceutical compounds

    SENTINEL ONCOLOGY LIMITED · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  5. US 10730882

    2-aminoquinazoline derivatives as P70S6 kinase inhibitors

    SENTINEL ONCOLOGY LIMITED · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  6. US 10344033

    2-aminoquinazoline derivatives as P70S6 kinase inhibitors

    SENTINEL ONCOLOGY LIMITED · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted
  7. US 10144726

    Modulators of the p70S6 kinase for use in the treatment of brain disorders and triple-negative breast cancer

    SENTINEL ONCOLOGY LIMITED · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted
  8. US 9630931

    Pharmaceutically active pyrazine derivatives

    SENTINEL ONCOLOGY LIMITED · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  9. US 8716287

    Pharmaceutical compounds

    SENTINEL ONCOLOGY LIMITED · Granted May 6, 2014 · Expires May 1, 2034

    granted
  10. US 8716473

    Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase

    SENTINEL ONCOLOGY LIMITED · Granted May 6, 2014 · Expires May 1, 2034

    granted
  11. US 8461339

    Pharmaceutical compounds

    SENTINEL ONCOLOGY LIMITED · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted